Abstract
The care of patients transitioning from adolescence to adult life always raises challenges for the clinician. This has proven to be especially true in the case of growth hormone (GH) treatment, in part due to the absence of any immediately observable consequences of the cessation of therapy. This paper describes the challenges involved in reestablishing the diagnosis of GH deficiency (GHD), titrating GH dosage, and sustaining patients on long-term GH treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 645-649 |
| Number of pages | 5 |
| Journal | Journal of Pediatric Endocrinology and Metabolism |
| Volume | 16 |
| Issue number | SUPPL. 3 |
| State | Published - 2003 |
Fingerprint
Keywords
- Children
- Clinical trial
- Diagnosis
- IGF-1
- IGFBP-3
- Pubertal dosing
- Somatotropin
- Somatropin
ASJC Scopus subject areas
- Endocrinology
- Pediatrics, Perinatology, and Child Health
Cite this
Transition from pediatric to adult care for growth hormone deficiency. / Rosenfeld, Ronald (Ron).
In: Journal of Pediatric Endocrinology and Metabolism, Vol. 16, No. SUPPL. 3, 2003, p. 645-649.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Transition from pediatric to adult care for growth hormone deficiency
AU - Rosenfeld, Ronald (Ron)
PY - 2003
Y1 - 2003
N2 - The care of patients transitioning from adolescence to adult life always raises challenges for the clinician. This has proven to be especially true in the case of growth hormone (GH) treatment, in part due to the absence of any immediately observable consequences of the cessation of therapy. This paper describes the challenges involved in reestablishing the diagnosis of GH deficiency (GHD), titrating GH dosage, and sustaining patients on long-term GH treatment.
AB - The care of patients transitioning from adolescence to adult life always raises challenges for the clinician. This has proven to be especially true in the case of growth hormone (GH) treatment, in part due to the absence of any immediately observable consequences of the cessation of therapy. This paper describes the challenges involved in reestablishing the diagnosis of GH deficiency (GHD), titrating GH dosage, and sustaining patients on long-term GH treatment.
KW - Children
KW - Clinical trial
KW - Diagnosis
KW - IGF-1
KW - IGFBP-3
KW - Pubertal dosing
KW - Somatotropin
KW - Somatropin
UR - http://www.scopus.com/inward/record.url?scp=0141960106&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141960106&partnerID=8YFLogxK
M3 - Article
VL - 16
SP - 645
EP - 649
JO - Journal of Pediatric Endocrinology and Metabolism
JF - Journal of Pediatric Endocrinology and Metabolism
SN - 0334-018X
IS - SUPPL. 3
ER -